DK76582A - Antimycotiske midler - Google Patents

Antimycotiske midler Download PDF

Info

Publication number
DK76582A
DK76582A DK76582A DK76582A DK76582A DK 76582 A DK76582 A DK 76582A DK 76582 A DK76582 A DK 76582A DK 76582 A DK76582 A DK 76582A DK 76582 A DK76582 A DK 76582A
Authority
DK
Denmark
Prior art keywords
antimycotic agents
formulation
antimycotic
weight
relative
Prior art date
Application number
DK76582A
Other languages
English (en)
Inventor
Miklos Von Bittera
Karl Heinz Buechel
Manfred Plempel
Erik Regel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6125514&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK76582(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK76582A publication Critical patent/DK76582A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/05—Stick

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
DK76582A 1981-02-23 1982-02-22 Antimycotiske midler DK76582A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813106635 DE3106635A1 (de) 1981-02-23 1981-02-23 Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Publications (1)

Publication Number Publication Date
DK76582A true DK76582A (da) 1982-08-24

Family

ID=6125514

Family Applications (1)

Application Number Title Priority Date Filing Date
DK76582A DK76582A (da) 1981-02-23 1982-02-22 Antimycotiske midler

Country Status (14)

Country Link
US (1) US4457938A (da)
EP (1) EP0058887B1 (da)
JP (1) JPS57156413A (da)
AT (1) ATE6988T1 (da)
AU (1) AU8032682A (da)
CA (1) CA1169770A (da)
DE (2) DE3106635A1 (da)
DK (1) DK76582A (da)
ES (1) ES509798A0 (da)
FI (1) FI820563L (da)
IL (1) IL65057A (da)
NO (1) NO820319L (da)
PH (1) PH18258A (da)
ZA (1) ZA821137B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3204124A1 (de) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen Antimykotische tampons mit hoher wirkstoff-freisetzung
DE3243546A1 (de) * 1982-11-25 1984-05-30 Bayer Ag, 5090 Leverkusen Antimykotische mittel in gelform zur behandlung von pilzinfektionen der mundhoehle
DE3244027A1 (de) * 1982-11-27 1984-05-30 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von gelsystemen
DE3311701A1 (de) * 1983-03-30 1984-10-04 Bayer Ag Antimykotische mittel mit hoher wirkstoff-freisetzung in form von creme
DE3311700A1 (de) * 1983-03-30 1984-10-04 Bayer Ag Antimykotische mittel mit hoher wirkstoff-freisetzung in form von loesung und spray
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US4636520A (en) * 1984-07-16 1987-01-13 Fujisawa Pharmaceutical Co., Ltd. Antifungal composition employing pyrrolnitrin in combination with an imidazole compound
DE3520098A1 (de) * 1985-06-05 1986-12-11 Bayer Ag, 5090 Leverkusen Azolderivate enthaltende formulierungen sowie ihre verwendung zur atraumatischen nagelentfernung
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
US4867971A (en) * 1988-04-22 1989-09-19 Colgate-Palmolive Company Low pH shampoo containing climbazole
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
JP2555555B2 (ja) * 1991-07-03 1996-11-20 武田薬品工業株式会社 抗真菌性外用製剤
AU4399793A (en) * 1992-06-08 1994-01-04 Schering-Plough Healthcare Products, Inc. Stable imidazole anti-fungal powder compositions
US5284649A (en) * 1992-09-29 1994-02-08 The Procter & Gamble Company Deodorant gel sticks containing 1-hydroxy pyridinethione active
EP2007390A4 (en) * 2006-04-04 2009-11-25 Avner Shemer TREATMENT KIT FOR SKIN INFECTION
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
SG11201602596UA (en) 2013-10-03 2016-04-28 Dow Pharmaceutical Sciences Stabilized efinaconazole compositions
EP3071295A4 (en) 2013-11-22 2017-05-31 Dow Pharmaceutical Sciences, Inc. Anti-infective methods, compositions, and devices

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799613A (en) * 1954-09-09 1957-07-16 Merck Ag E Fungicides and bactericides and process of applying
US3502594A (en) * 1965-12-28 1970-03-24 Gerhard W Ahrens Synergistic antioxidant composition for natural oleaginous materials
US3483008A (en) * 1966-08-01 1969-12-09 Daniel A Naeve Method of preparing a water-soluble protein lotion
US3903287A (en) * 1971-02-05 1975-09-02 Bayer Ag Imidazolyl ketones for treating mycotic infections
GB1327853A (en) * 1971-05-24 1973-08-22 Ici Ltd Griseofulvin compositions
US3856931A (en) * 1972-08-01 1974-12-24 Schering Ag Medicated stick
DE2430039C2 (de) * 1974-06-22 1983-11-10 Bayer Ag, 5090 Leverkusen Climbazol in kosmetischen Mitteln
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE2851116A1 (de) * 1978-11-25 1980-06-12 Bayer Ag Hydroxyethyl-azole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4268498A (en) * 1979-07-16 1981-05-19 Revlon, Inc. Clear cosmetic sticks

Also Published As

Publication number Publication date
CA1169770A (en) 1984-06-26
US4457938A (en) 1984-07-03
PH18258A (en) 1985-05-13
ATE6988T1 (de) 1984-04-15
DE3260099D1 (en) 1984-05-17
IL65057A0 (en) 1982-04-30
EP0058887A1 (de) 1982-09-01
ES8303092A1 (es) 1983-02-01
JPS57156413A (en) 1982-09-27
AU8032682A (en) 1982-09-02
ZA821137B (en) 1983-01-26
DE3106635A1 (de) 1982-09-09
IL65057A (en) 1985-06-30
ES509798A0 (es) 1983-02-01
NO820319L (no) 1982-08-24
EP0058887B1 (de) 1984-04-11
FI820563L (fi) 1982-08-24

Similar Documents

Publication Publication Date Title
DK76582A (da) Antimycotiske midler
AU534447B2 (en) Hydroxyethyl-imidazoles and triazole derivatives and their use as antimycotic actents
IT8022637A0 (it) Uso di composti perfluorocarburici per il trattamento di lesioni,articoli e composizioni contenenti detti composti
AU536920B2 (en) Hydroxypropyl-triazole derivatives and their use as antimycotic agents
IT8319857A0 (it) Agenti antiflogistici/antipiretici/analgesici contenenti derivati di teobromina o teofillina come ingrediente attivo.
FI813912L (fi) I laekemedel anvaendbara tricykliska cytosinderivat och foerfarande foer deras framstaellning
JPS5533497A (en) Silaasubstituted 1*44dihydropyridine derivative
DE3363350D1 (en) Pesticidal formulations
ES492143A0 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
ES525297A0 (es) Procedimiento para la obtencion de derivados de terc.-butanol sustituidos
DE69207777D1 (de) Körperpflegemittel
IT1136568B (it) Composizioni per l'idratazione delle sostanze cheratiniche,costutuite da solfossidi di alfa-ammino-acidi
IT1191211B (it) Procedimento per la preparazione di nitroaniline,nitroaniline e composizioni tintorie comprendenti nitroaniline
ATE22005T1 (de) Cremegrundlage.
IT7920267A0 (it) Derivati fenossifenossi non saturi e composizione erbicida.
FI822331L (fi) Blandningar foer lokal anvaendning pao huden
MX9204815A (es) Hexahidrobenzo[f]quinolinonas y formulacion farmaceutica que las comprende.
ATE33759T1 (de) Antimykotische mittel in gelform zur behandlung von pilzinfektionen der mundhoehle.
IT8068139A0 (it) Derivati di 1 sostituiti 3cicloalchil solfonil pirrolidin 2 5dioni composizioni fungicide che licontengono e procedimento per lapreparazione degli ingredienti attivi nonche delle composizioni
IT7922548A0 (it) Derivati del 1,5-dimetilbiciclo(3.2.1.)-ottano, preparazione di questi composti eloro impiego come composti per profumi.
DK151082A (da) Fungicidt middel indeholdende triazolylderivater
IT8068312A0 (it) Impiego di imidazoli 1 sostituiti nella preparazione di composizioni contraccettive

Legal Events

Date Code Title Description
ATS Application withdrawn